Source comparison
Melanotan-2 News 2026: Comparison of Regulatory and Research Status
Melanotan-2's legal and scientific standing varies dramatically depending on whether you're asking about human use, research applications, or regulatory enforcement. The table below summarises the 2026 status across key jurisdictions and contexts. United State
This comparison does not assign a generated winner or score.
- Melanotan-2's legal and scientific standing varies dramatically depending on whether you're asking about human use, research applications, or regulatory enforcement. The table below summarises the 2026 status across key jurisdictions and contexts.
- United States (FDA)
- Unapproved drug; not a supplement
- Legal for in-vitro research if supplier does not market for human use
- 14 warning letters to consumer-facing vendors (Jan–Apr)
- Research use legal but sourcing must be from non-consumer suppliers
- European Union (EMA)
- Substance of very high concern (Article 57 database)
- Legal for licensed research only; customs seizures for personal imports
- Germany, France, Netherlands seizing shipments >10mg
- Research institutions require import licenses; personal use de facto blocked
- Australia (TGA)
- Schedule 9 (prohibited substance as of Feb 2026)
- Requires research license; possession without license is criminal offense
- Active enforcement; 23 prosecutions filed in Q1 2026
- Effectively banned except for pre-approved academic labs
- Academic Receptor Research
- Research tool for melanocortin pathway studies
- Widely used in MC1R/MC4R binding assays and melanogenesis models
- No restrictions when sourced for non-human studies
- Legitimate and valuable research reagent
- Compounding Pharmacies (503B)
- Not eligible for compounding; no FDA approval pathway
- Cannot be legally compounded for human prescription
- N/A
- No legal human therapeutic route exists